COVID Data Initiative (INCODA)
- Funded by Netherlands Organisation for Health Research and Development (ZonMW)
- Total publications:0 publications
Grant number: 1.043E+13
Grant search
Key facts
Disease
COVID-19Start & end year
20202022Funder
Netherlands Organisation for Health Research and Development (ZonMW)Principal Investigator
N. BreedveldResearch Location
N/ALead Research Institution
Amsterdam Health and Technology InstituteResearch Priority Alignment
N/A
Research Category
Epidemiological studies
Research Subcategory
Disease susceptibility
Special Interest Tags
Data Management and Data Sharing
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Within the project, a dataset has been built of almost all residents of the Netherlands, linked to the GGD test results and COVID-19 related hospital and ICU admissions and deaths. This combined dataset was then used to examine both the risk of infection and the risk of hospital admission, ICU admission and/or death. All results show that socio-demographic factors, such as income, age and migration background, strongly influence both the risk of a SARS-Cov-2 infection and the risk of a serious course of COVID-19. It also becomes clear that it may differ per city or safety region which group has the highest risk of infection. There is a dashboard with the available (anonymous) data developed which makes it possible for everyone to get a detailed picture of which groups tested where and at what time, tested positive for the coronavirus, who was in hospital and who died as a result of the virus. The objectives of INCODA are: 1. Identify groups at high risk for a COVID-19 infection with a serious course 2. Investigate whether the combination of medical characteristics and clinical parameters with geographical, demographic and socio-economic characteristics is valuable and can be used for, among other things, secondary prevention measures and choosing treatment methods INCODA does this by: • combining clinical and ICU admission data of COVID-19 patients with CBS data • identifying risk groups based on a multivariable profile and developing prediction models for the risk of a serious course of COVID-19 • investigating possible interventions